Patheon® is a leading provider of drug substance and drug product services for the global biopharmaceutical industry. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Introducing DPx Holdings B.V.


DPx Holdings B.V. is the “umbrella name” for our three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies. Formed as part of a USD $2.6 billion transaction between JLL Partners and Royal DSM in March 2014, we are positioned to add scale, new value chain capabilities and technologies, as well as expand our end-to-end service offerings as a comprehensive solution provider to the pharmaceutical industry.

Emerged from the shared vision between Patheon and DSM Pharmaceutical Products (DPP) – the DPx vision is built upon the collective reputations of quality, innovation, customer service and operational excellence. These same core commitments are at the center of each of our business units, which operate under the PatheonDPx Fine Chemicals and Banner Life Sciences brand names.

Each business unit provides offerings that complement the value to each customer but unique in their individual value offering:

Patheon® is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms,including small molecule API and biologic drug substances. Patheon, a businessunit of DPx Holdings B.V., encompasses the combined commercial manufacturing capabilities and pharmaceutical product development services, as well as offers a full array of biologic services and active pharmaceutical ingredients (API) development. Patheon is #1 in product development services, #2 in commercial scale product manufacturing and is #1 in quality.

DPx Fine Chemicals™, formerly DSM Fine Chemicals, is a business unit of DPx Holdings B.V., and is a leading provider of high-quality fine chemicals including agricultural and crop protection products, intermediates and maleic anhydride tree chemicals. The primary focus of DPx Fine Chemicals is partnering with companies in the custom synthesis of their unique compounds; it also offers a portfolio of fine chemical products important for multiple industries. For more information, visit

Established in 2013, Banner Life Sciences™ was formed as a result of the acquisition of Banner Pharmacaps by Patheon®. Banner Life Sciences is now a business unit of DPx Holdings B.V. and is dedicated to the research and development, in-licensing, out-licensing and commercialization of innovative formulation technologies, as well as the marketing of prescription, over-the-counter and nutritional proprietary products. For more information, visit

DPx Holdings B.V. Leadership

James C. Mullen

James C. Mullen

Chief Executive Officer

Mr. Mullen is currently Chief Executive Officer of Patheon. He joined Patheon Inc. in 2011 as CEO and has continuously contributed to the company’s growth. +

Stuart Grant

Stuart Grant

Chief Financial Officer and Executive Vice President of Finance and IT

Mr. Grant is currently Chief Financial Officer and Executive Vice President of Finance and IT at Patheon. +

Rebecca Holland New

Rebecca Holland New

Chief Human Resources Officer & Sr. Vice President of Corp. Communications

Mrs. Holland New serves as Chief HR Officer and Senior Vice President of Human Resources and Corporate Communications at Patheon. +

Michael Lytton

Michael Lytton

Executive Vice President of Corporate Development and Strategy

Michael Lytton is currently Executive Vice President of corporate development and strategy at Patheon. Lytton also leads the company's product and technology business Banner Life Sciences. +

Eric M. Sherbet

Eric M. Sherbet

General Counsel and Secretary

Based in Boston, Mass., Mr. Sherbet serves as the General Counsel, overseeing all global legal affairs, corporate compliance and regulatory matters, in addition to his role as secretary of the company’s board of directors. +

For information related to the company's finances, leadership or strategy, please email

Knowledge Library

Please fill the below form to access requested content

First Name

Last Name





Address Line 1

Address Line 2


Zip/ Postal Code